{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:31:22Z","timestamp":1768437082948,"version":"3.49.0"},"reference-count":37,"publisher":"Academy of Managed Care Pharmacy","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.18553\/jmcp.2023.23031","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T08:24:12Z","timestamp":1696062252000},"page":"1205-1218","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of health care costs and resource utilization for commonly used proteasome inhibitor\u2013immunomodulatory drug-based triplet regimens for the management of patients with relapsed\/refractory multiple myeloma in the United States"],"prefix":"10.18553","volume":"29","author":[{"given":"Larysa","family":"Sanchez","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajai","family":"Chari","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu","family":"Cheng","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dasha","family":"Cherepanov","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Lexington, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maral","family":"DerSarkissian","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Huang","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Lexington, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn Marie","family":"Stull","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Lexington, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Dabora","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Lexington, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Young","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Lexington, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Noga","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Lexington, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selina","family":"Pi","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody","family":"Zhang","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeem","family":"Banatwala","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei Sheng","family":"Duh","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sikander","family":"Ailawadhi","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Jacksonville, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2011.0095"},{"key":"R2","unstructured":"SEER. Cancer Stat Facts: Myeloma. National Cancer Institute. Bethesda, MD. Accessed April 21, 2022. https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.380"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_200869"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.4516.4516"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116129"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.313"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0384-1"},{"key":"R13","first-page":"217","volume":"10","author":"Muz B","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411321"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516282"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.1663"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2016.1127754"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30756-7"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.329"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1729734"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04534-8"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1132225"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200208000-00007"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-615187"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6607"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1080\/03610910902859574"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq439"},{"key":"R30","unstructured":"Vallentine D. Revlimid Generic Appears on the Myeloma Market. HealthTree Foundation for Multiple Myeloma. 2022. Accessed February 16, 2022. https:\/\/healthtree.org\/myeloma\/community\/articles\/finally-a-biosimilar-for-revlimid-and-why-the-cost-of-revlimid-came-to-be"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1867469"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.01.009"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2019.25.4.449"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2012.760159"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2021.2009648"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103842"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20170304"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30452-6"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.01.018"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00359-2"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-299487"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-647636"}],"container-title":["Journal of Managed Care &amp; Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T15:40:56Z","timestamp":1700062856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2023.23031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.18553\/jmcp.2023.23031"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2023.23031","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}